Showing 1 to 1 of 1 results
elmundo.es
🌐 85% Global Worthiness


Annual HIV-Prevention Injection Shows Promise in Phase 1 Trial
A phase 1 trial showed a single intramuscular injection of lenacapavir provided effective HIV prevention for at least 56 weeks in 40 participants, potentially revolutionizing PrEP access and adherence, with a semiannual version under regulatory review.
Annual HIV-Prevention Injection Shows Promise in Phase 1 Trial
A phase 1 trial showed a single intramuscular injection of lenacapavir provided effective HIV prevention for at least 56 weeks in 40 participants, potentially revolutionizing PrEP access and adherence, with a semiannual version under regulatory review.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results